Market Research Future

  Global Bowel Management Systems Market Overview Market Research Future (MRFR), in their recently launched report, has asserted that the global  Bowel management systems market  The Bowel Management Systems Market is expected to reach USD 2.00 Billion by 2030 at 3.60% CAGR during the forecast period 2022-2030. A rapid change in lifestyles of the general public has led to a surge in the intestinal issues such as constipation and fecal incontinence. Advancements in healthcare technology, along with various technological developments in medical devices, has pushed sizeable growth in the bowel management systems market. Further, the rise of the geriatric population, across the globe, has propelled the surging bowel management systems market. Additionally, the dietary imbalance caused due to the consumption of unhealthy food is also causative of fast-paced growth noted in the global bowel management systems market. However, on the other hand, concerns regarding the discomfort associated wi

  The Medical Document Management Systems Market is expected to record a CAGR 10.8% to reach USD 2.8 billion during the forecast period 2022 to 2030. Medical document management systems are software with the capacity of storing, management, and retaining of patient documents. The changes in the healthcare sector, investments in healthcare IT, and inflow of patients are factors discussed in detail in the global  Medical Document Management Systems Market  report by Market Research Future (MRFR). The COVID-19 pandemic and its impact on the market are explored as well. Market Scope The global medical document management systems market size is touted to expand at a momentous growth rate owing to the increasing volume of data to be acquired in the coming years. The large influx of patients, shift to electronic health records, and the prevalence of various diseases are all main factors driving market growth. Maintenance, continuous updates, and a bid to curb rising healthcare costs can fuel

  Market Research Future (MRFR)’s latest report projects that the global  Pharmaceutical Robots Market  is set to exhibit substantial growth over the next couple of years. The growth is attributable to the strong value maintained by the pharmaceutical industry. The utilization of robots mitigates the production cost and human labor, which is likely to accelerate its adoption in the forthcoming years. Laboratory automation is one of the most significant drivers of the global pharmaceutical robots market. It aids easy and timely accomplishments of the tasks such as transferring, capping, uncapping, packaging, etc. as well as eliminates human errors. Furthermore, pharmaceuticals robotics are extensively used for scientific researches, drug discoveries, blood testing, etc. This, in turn, is projected to have a favorable impact on the expansion of the market in the coming years. The endeavors of the key players are directed towards technological advancements and innovations. It has opened n

  The emergence of technologically advanced devices has prompted the inception and the eventual market growth of  Smart Medical Device Market . The advanced form of technology is helping pharmaceutical as well as biotechnological companies to develop safer options for biologics and other drugs that are administered through intravenous infusion. According to the latest report conducted by Market Research Future (MRFR), the global smart medical devices market is expected to witness increasing growth and demand during the forecast period of 2022-2030. Smart medical devices market size is projected to reach USD 23.50 billion by 2027 end, at a CAGR of 23.5%.  The shift of commercialized patient-centric biologics from intravenous infusion technique to subcutaneous injection has paved new growth opportunities for the global Smart Medical Devices market. Also, there has been a growing impetus on self-administration of biologics and a shifting inclination towards the adoption of these medically

  Market Highlights The wearable injectors market can expect to reach USD 21.98 billion at 15.2% CAGR from 2022-2030 Wearable injectors are drug delivery instruments for convenient administration of viscous drugs. They are also known as bolus injectors or patch pumps. Wearable injectors are used to subcutaneously administer insulin and other drugs that require large dose volumes and extended delivery period. The increasing prevalence of various chronic diseases, rising concern for injuries caused due to needles and increasing demand for round the clock monitoring are expected to drive the growth of the market during the forecast period. Additionally, the technological advancements in wearable injectors and growing geriatric population are likely to boost the market growth. On the other hand, preference for traditional methods of drug administration and lack of skilled labor who can instruct patients about wearable injectors and its usage may hinder the growth of the market during the f

  Market Scope The Stem Cell Therapy Market is projected to reach USD 92.08 Million by 2030 at 16.20% CAGR during the forecast period 2022-2030. Drivers and Restrains Impacting Stem Cell Therapy Market The surge in awareness about therapeutic applications of stem cells in the management of several disease is expected to drive the expansion of the global stem cell therapy market in the near future. The growth of the stem cell therapy market can be attributed to the tremendous increase in the demand for effective therapeutic solution for malignancy and the prevent heart diseases, osteoarthritis, and stroke among others. The prevailing sedentary lifestyle, increase in consumption of alcohol, and rise in number of smokers can contribute the upsurge of the stem cell market in the years to come. On the contrary, the stem cell therapy market value generation can drop owing to the high expense of surgical procedures, chemotherapy treatments, the increase in risk of body cell rejecting cells de

  Market Highlights Distraction osteogenesis (DO), also called callus distraction, callotasis, osteodistraction, and distraction histogenesis is a surgical process used to reconstruct skeletal deformities and lengthen the bones of the body. Rising incidence and prevalence rates of birth defects boost the market growth whereas various risks involved with the distraction osteogenesis surgery hinder the market growth. According to the survey carried out by Craniosynostosis and Positional Plagiocephaly Support (CAPPS) Organization, 2014, the incidence of craniosynostosis is around 1 in 2,000/3,000 births, accounting for 175 infants born each day, with craniosynostosis globally. Regional Analysis North America is expected to dominate the global  Distraction Osteogenesis Devices Market  owing to increasing number of procedures for treating facial abnormalities in the US. The European market is expected to be the second-largest due to increase in initiatives taken by public and private organi

  Market Highlights  The latest report by Market Research Future (MRFR) states that the Respiratory Syncytial Virus (RSV) market is all set to gain substantial traction by accruing gigantic revenues by 2030. In addition, it is on track to surge at a CAGR of 10.7 % during the forecast period (2022-2030). Market Drivers and Top Restraints  The document named “Reducing Neonatal Mortality and Morbidity in Latin America And the Caribbean, An Interagency Strategic Consensus” states that almost 400,000 children under the age of five die due to infections that could have been prevented. This has attracted the focus of various health agencies that are striving to get a hold of the issue. For instance, Latin American Center for Perinatology and Pan America Health Organization (PAHO) have diverted their focus in the direction of educating the parents to fight against possible infections, promoting the growth of the RSV diagnostics market in the process. The boost in the number of product launches

  Regional Analysis The  Transradial Access Devices Market  consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Transradial Access Devices market is projected to reach USD 2.25 Billion by 2030 at 7.60 % CAGR during the forecast period 2022-2030.  The Americas dominated the global transradial access devices market owing to the use of transradial access devices for detection of cardiovascular diseases along with the demand for early diagnosis. For instance, a study conducted by the Centers for Disease Control and Prevention (CDC) reported that in 2017, 2.7 to 6.1 million people in the United States have (atrial fibrillation) AFib, leading to more than 750,000 hospitalizations each year in the U.S. The European region is the second largest market for global transradial access devices due to surging cases of obesity along with the increasing number of chemotherapy procedures and growing use of radial access devices in pediatric patients. The

  Healthcare Sector The global   Autoimmune Disease Treatment Market   is projected to reach USD 2,104 Million by 2030 at 6.90% CAGR during the forecast period 2022-2030.  The global autoimmune disease treatment market is mainly driven by the growing prevalence of autoimmune diseases, the growing awareness about autoimmune disease treatment, and the growing development of a number of effective treatments for autoimmune diseases based on modern medical processes such as genomics. Autoimmune diseases are diseases caused by the immune system mistaking the body’s own tissue for foreign tissues and attacking it. This can happen due to a number of complications within the immune system and can have disastrous consequences on the health of the individual. Some of the most widely prevalent autoimmune diseases include rheumatoid arthritis, lupus, and multiple sclerosis. Growing awareness about autoimmune diseases and their treatment is likely to be a major driver for the global autoimmune dis

  Market Highlights: The heart scan market is anticipated to reach USD 12,435 Million by 2030 at 6.54% CAGR during the forecast period 2022-2030. Over the last few years, healthcare IT has gained a significant importance as the adoption of the software solutions and computer-aided diagnosis has increased the efficacy of the treatment. Increasing prevalence of cardiovascular diseases, adoption of advanced techniques in diagnosis, and increasing government support have driven the growth of the  Heart Scan Market . According to the World Health Organization, 422 million people across the globe are suffering from diabetes. Diabetes is the major reason for cardiovascular diseases. Increasing prevalence of diabetes, rapidly developing technology, and increasing geriatric population across the globe is fuelling the growth of the market. However, strict regulations are to be followed by the manufacturer for the development of the devices. Strict regulatory rules and the high cost of some of th

  Occlusion Devices Market Analysis The global  Occlusion Devices Market  is expected to reach USD 2,193.98 Million by 2030 at 6.2% CAGR during the forecast period 2022-2030.   Occlusion refers to the closure/blockage of any organs or blood vessels. Occlusion devices, simply put, are a type of medical device which is used to treat various conditions and defects in the patient’s body, including gynecology, oncological, neurological, cardiovascular, and others. They are clinically tested as well as deemed effective to remove occlusion from different parts of the body.  Numerous factors are propelling the occlusion devices market. Such factors, as per the new Market Research Future report, include increase in geriatric population, treatment under health insurance policies, government and private organizations covering the cost of occlusion devices, increasing prevalence of neurological and heart-related disorders, increasing availability of medical reimbursements, rising use of surgical t